News – Page 359 – Endpoints News

Judge allows expert testimony in GSK trial alleging Zantac link to cancer

3 years ago

Q&A: BioCina’s new CEO Mark Womack on the CDMO he says is 'worth traveling over'

3 years ago

Novo Nordisk oral semaglutide trial shows reduction in blood sugar, plus weight loss

3 years ago

Abbott introduces the Melon family to raise concussion awareness

3 years ago

Senate committee advances PBM bill as bipartisan reforms gain traction

3 years ago

Lyme vaccine test completion is pushed back by a year as Pfizer, Valneva say they'll adjust trial

3 years ago

Stuart Peltz resigns as PTC Therapeutics CEO after 25 years

3 years ago

89bio to net $275M from stock offering; Assembly Bio to pause work on one HBV inhibitor program

3 years ago

Better Therapeutics cuts 35% of staff while awaiting digital therapeutic approval

3 years ago

AbbVie says it has positive mid-stage data for Rinvoq in lupus, will move to PhIII

3 years ago

FDA spells out how cancer drug developers can use one trial for both accelerated and full approvals

3 years ago

Relmada makes 'critical changes' to PhIII trial to try and save depression drug

3 years ago

NK cell therapy-focused biotech eyes SPAC deal

3 years ago

Incyte hit by CRL on extended-release JAK tablets, muddying plans for Jakafi franchise expansion

3 years ago

Hard pressed for cash, Cyclerion looks for help funding rare disease drug

3 years ago

Brii Biosciences stops manufacturing Covid-19 antibody combo, plans to withdraw EUA request

3 years ago

Three's a crowd as another Kite exec hits the exit; Surfing tough waters, Celyad Oncology picks up new CEO

3 years ago

Patients appeal NIH's rejection to use 'march-in' rights on Astellas' prostate cancer drug Xtandi

3 years ago

Takeda and Lundbeck change tactics on Trintellix depression campaign

3 years ago

European Commission delays proposal for major changes to pharma legislation

3 years ago

Bristol Myers’ ‘Living’ documentary ties together people managing health conditions

3 years ago

Secura Bio to keep offering blood cancer drug despite negative ODAC vote, OS questions

3 years ago

J&J loses attempt to extend patent in India for tuberculosis drug

3 years ago

White House unveils ‘bold goals’ for US biomanufacturing efforts

3 years ago

First page Previous page 356 357 358359360 361 362 Next page Last page